Comparison results
| Results: Differences General | ✘Tolochinov's disease–Roger | ✘CLC syndrome | |||||||
| Related research | Analogs | Analogs | |||||||
| |||||||||
| Distinctive symptoms | |||||||||
| Register, to see more distinctive signs of diseases and studies | 28% | — | |||||||
| Register, to see more distinctive signs of diseases and studies | — | 58% | |||||||
| weakness after stress | 27% | — | |||||||
| qrs interval duration lowered | — | 30% | |||||||
| hypertrophy of the left ventricle | 25% | — | |||||||
| tachycardia attacks | — | 28% | |||||||
| from left to right | 25% | — | |||||||
| wolf-parkinson-white syndrome | — | 28% | |||||||
| heart hypertrophy | 22% | — | |||||||
| rheumatic mycarditis | — | 27% | |||||||
| weakness in the heart | 16% | — | |||||||
| lowered | — | 25% | |||||||
| tolochinov's disease–roger | 16% | — | |||||||
| tachycardia | — | 24% | |||||||
| bronchial lesion | 14% | — | |||||||
| palpitations | — | 23% | |||||||
| there is heart failure | 14% | — | |||||||
| parkinson's disease | — | 23% | |||||||
| heart failure | 14% | — | |||||||
| left atrium volume lowered | — | 23% | |||||||
| lags behind in the development | 13% | — | |||||||
| arrhythmia | — | 20% | |||||||
| presses | 13% | — | |||||||
| CHD | — | 19% | |||||||
| weakness after illness | 13% | — | |||||||
| supraventricular tachycardia | — | 19% | |||||||
| impaired lung function | 12% | — | |||||||
| damage to the nervous system | — | 18% | |||||||
| drug disease | 12% | — | |||||||
| acute expansion of the heart | — | 18% | |||||||
| history of surgery | 11% | — | |||||||
| volume of thyroid gland is reduced | — | 18% | |||||||
| angioplasty | 21% | 12% | |||||||
| atrioventricular block | — | 18% | |||||||
| increased | 19% | 11% | |||||||
| rheumatism | — | 17% | |||||||
| weak heart | — | 17% | |||||||
| supraventricular arrhythmia | — | 17% | |||||||
| take it, take it | — | 17% | |||||||
| arrhythmia attacks | — | 16% | |||||||
| diffuse toxic goiter | — | 16% | |||||||
| thyrotoxicosis | — | 16% | |||||||
| enlargement of the thyroid gland | — | 16% | |||||||
| nervous excitability | — | 16% | |||||||
| arrhythmia tachycardia | — | 16% | |||||||
| beriberi | — | 15% | |||||||
| n | — | 15% | |||||||
| myocardial infarction | — | 15% | |||||||
| thyroid diseases | — | 15% | |||||||
| essential hypertension | — | 14% | |||||||
| hormonal disorders | — | 13% | |||||||
| hypertension | — | 13% | |||||||
| necrosis | — | 13% | |||||||
| there are no complaints | — | 12% | |||||||
| impaired arterial function | — | 12% | |||||||
| heart dysfunction | 12% | 18% | |||||||
| cardiodilation | 15% | 15% | |||||||
| enlargement of the heart | 15% | 15% | |||||||
Instructions
Video
|